We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cineworld Group Plc | LSE:CINE | London | Ordinary Share | GB00B15FWH70 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.381 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/1/2021 09:36 | I don't the share price keeps rising, the market see's 100p before long. dyor | srpactive | |
12/1/2021 08:08 | I think all spring and summer films will be moved to autumn now or release on streaming services | lennonsalive | |
12/1/2021 07:44 | looks finished tbh | thomasearnshaw | |
12/1/2021 07:35 | Sony Pushes Back Morbius' Release Date To October | lennonsalive | |
11/1/2021 23:49 | Unfortunately I think you are right. It is extremely sad but I am used to staying in now and watching films at home. It would have to be a blockbuster to get me out to a cinema and as others have said this will be late summer earliest. Government have committed to vaccine for all by autumn, this is ambitious and does not solve all the problems. | coldspring | |
11/1/2021 23:31 | Loads of films delayed, so Cineworld won't open for ages. I reckon late Summer | lennonsalive | |
11/1/2021 22:56 | No Time to Die delayed ... againhttps://theplay | lennonsalive | |
11/1/2021 22:50 | 30p initial target. Value the assets on a fire-sale basis. The death of cinema, sad ? | valuetracker | |
11/1/2021 22:45 | Jangho piling in ain’t they. Interesting to see if they do anything with a sizeable percentage | ckafetz | |
11/1/2021 17:51 | No one is walking into a cinema anytime soon - too much debt and slow roll out of vaccine will bury this one I'm afraid. New players will pick up the pieces on the cheap. This is a deluded thread - time to get real - you've got more chance of covid death than Cineworld coming back to life. Will be missed. Sad. | moneysage | |
11/1/2021 16:43 | rns MS increased too. dyor | srpactive | |
11/1/2021 16:04 | RNS Jangho increased further now to 12.17% from 11%.. The chinese are coming. dyor | srpactive | |
11/1/2021 11:58 | The funding is in place Doors are closed until April as the company has stated. Vaccine is rolling out well, 350m doses order by UK, all over 50's vaccinated by end March. Teachers talking of return by March. All good, come on 100p. dyor | srpactive | |
08/1/2021 15:37 | Holding rns GS increased further, dyor edit another the other way for MS. | srpactive | |
08/1/2021 14:29 | Expecting 100p before end January, peak covid figures next week. Then massive entertainment program for Spring. dyor | srpactive | |
08/1/2021 13:40 | Today - Morgan Stanley Underweight lower PT now 40p from 45p. 'We expect a slow US box office recovery (~50% of 2019) and streaming risks to escalate. We forecast another year of cash burn,exiting FY21 with 5.2x ND/normalised EBITDA' Lengthy report but nothing positive on Cineworld. MS also believe they will underperform their competitors in US due to poor estate. Time to short? | hades1 | |
08/1/2021 10:47 | That chart is looking super handsome now. p Was that before they surged 600%? | srpactive | |
08/1/2021 08:43 | Another Chinese group were massively invested in Thomas Cook adding 1% or so most weeks right up to the endThat worked out well for share holders. | privileged | |
08/1/2021 08:08 | If it involves offering 100p, per share I think I might. dyor active | srpactive | |
07/1/2021 23:27 | You might not like their plans - Looks like more leverage is needed. | hades1 | |
07/1/2021 19:56 | Jangho INCREASE HOLDING RNS to 11% after hours. GS INCREASE HOLDING RNS to 7% late on. I feel something about to happen. dyor active | srpactive | |
07/1/2021 15:15 | Nice day for the longs | ckafetz |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions